导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -4.71% | 3336/4773 |
| 近一周 | -2.01% | 3953/5467 |
| 近一月 | -3.23% | 1169/5421 |
| 近一季 | -2.05% | 1251/5238 |
| 近半年 | -2.70% | 2429/4931 |
| 近一年 | -1.72% | 2884/4400 |
| 近两年 | 33.63% | 2132/2954 |
| 近三年 | 20.33% | 1453/2253 |
| 成立以来 | 58.40% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.56% 4162/4961 |
6.42% 2832/5312 |
- - |
- - |
| 2025 | 15.52% 2536/4813 |
-0.64% 2331/3635 |
2.79% 1349/4076 |
11.01% 3211/4524 |
1.89% 1169/4813 |
| 2024 | 17.88% 642/3463 |
3.52% 555/2808 |
-0.14% 691/3014 |
16.91% 1313/3129 |
-2.47% 2096/3463 |
| 2023 | -9.18% 1120/2656 |
0.79% 1696/2280 |
-4.73% 1268/2385 |
1.68% 290/2515 |
-6.98% 2002/2655 |
| 2022 | -17.08% 548/2207 |
-11.30% 497/1919 |
6.50% 685/2016 |
-13.49% 910/2113 |
1.46% 1256/2208 |
| 2021 | -4.20% 944/1822 |
-1.88% 550/1255 |
1.05% 1071/1330 |
-5.81% 862/1466 |
2.58% 560/1822 |
| 2020 | 26.66% 599/1250 |
-10.31% 770/1028 |
11.70% 718/1067 |
11.48% 444/1164 |
13.41% 363/1184 |
| 2019 | 39.90% 267/1092 |
23.13% 563/754 |
4.26% 36/804 |
1.36% 410/850 |
7.52% 427/918 |
| 2018 | - - |
- - |
- - |
- - |
-12.22% 425/691 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4796 | 32.41% |
| 港股通药 | 0.9109 | 32.37% |
| 万家中证港股通创新药ETF | 1.6293 | 32.25% |
| 景顺长城中证港股通创新药ETF | 1.6918 | 32.17% |
| 天弘恒生沪深港创新药精选50ETF | 0.8599 | 32.08% |
| 港股医疗 | 0.9703 | 31.90% |
| 港医疗 | 0.9212 | 31.83% |
| 港股通医疗ETF工银 | 0.9798 | 31.81% |
| 港股通医疗ETF华宝 | 0.9918 | 31.64% |
| 万家中证港股通创新药ETF发起式联接A | 1.4193 | 31.06% |
| 申万菱信上证50ETF VS. 长安沪深300非周期A(740101) |